EUVIMEDEUVIMED entdecken
Crossref

Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts

Erin Jay G Feliciano iD, Urvish Jain iD, Edward Christopher Dee iD, Aryan Selokar, J Richelyn Baclay iD, James Fan Wu iD, Frances Dominique V Ho iD, Bhav Jain iD, Tej A Patel iD, Nishwant Swami iD, Kaisin Yee, Kaitlyn Lapen iD und 12 weitere

JCO Global Oncology · 2025

DOI: 10.1200/go-25-00206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Erin Jay G Feliciano und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, Queens, NY. Hauptthemen laut MEDLINE: Hematologic Neoplasms. Die Arbeit nennt 53 Literaturangaben. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Southeast Asia (SEA), home to over 690 million people across 11 countries—Brunei, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor-Leste, and Vietnam—features diverse socioeconomic contexts and cancer care landscapes. We report and interpret incidence and mortality statistics for hematologic malignancies (HMs) in SEA. METHODS We analyzed 2022 Global Cancer Observatory data from the International Agency for Research on Cancer to report age-standardized incidence rate (ASIR) and age-standardized mortality rates (ASMR) per 100,000 individuals age 20 years and older. We focused on non-Hodgkin lymphoma (NHL), leukemia, multiple myeloma (MM), and Hodgkin lymphoma (HL), standardized using Segi-Doll world population estimates. RESULTS Across 11 Southeast Asian countries, age-standardized incidence and mortality rates (ASIRs and ASMRs) for HMs vary widely, highlighting significant regional disparities. Singapore consistently reports the highest ASIRs for NHL, leukemia, MM, and HL, yet its ASMRs are much lower, reflecting strong health care infrastructure. Thailand, Brunei, and Malaysia mirror these associations, which are particularly pronounced in NHL and HL. In contrast, for leukemia and MM, Brunei, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Timor-Leste, and Vietnam demonstrated lower ASIR and ASMR that approaches ASIR, suggesting barriers to diagnosis and survivorship. Time trends suggest increasing mortality from MM and NHL, particularly in Thailand and the Philippines. Overall, survival outcomes correlate strongly with national health care capacity. CONCLUSION Higher reported incidence in wealthier SEA countries may reflect greater diagnostic capacity, whereas similar incidence and mortality in low-income countries likely indicates limited access to timely diagnosis and treatment. Mortality patterns underscore the region's broad disparities in cancer care infrastructure and outcomes, shaped by socioeconomic and systemic health inequities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsHumansAsia, SoutheasternIncidenceAdultMaleFemaleMiddle AgedYoung AdultAged

Autor:innen und Institutionen

  • Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, Queens, NY.
  • School of Medicine and Public Health, Ateneo de Manila University, Pasig City, Philippines.
  • Bennett School of Public Policy, University of Cambridge, Cambridge, UK.
  • School of Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • University of California San Diego, La Jolla, CA.

ORCID-Profile: Erin Jay G Feliciano, Urvish Jain, Edward Christopher Dee, J Richelyn Baclay, James Fan Wu, Frances Dominique V Ho, Bhav Jain, Tej A Patel, Nishwant Swami, Kaitlyn Lapen, Rod Carlo Columbres, Navin Bhatt, Adrian E Go, Brandon S Imber, Imjai Chitapanarux, Frederic Ivan L Ting, Gin-Gin Gan, Nirmala Bhoo-Pathy

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Feliciano, E. J. G., Jain, U., Dee, E. C., Selokar, A., Baclay, J. R., Wu, J. F., Ho, F. D. V., Jain, B., Patel, T. A., Swami, N., Yee, K., Lapen, K., Columbres, R. C., Bhatt, N., Go, A. E., Imber, B. S., Chitapanarux, I., Ting, F. I. L., Tremblay, D., …, & Bhoo-Pathy, N. (2025). Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts. JCO Global Oncology. https://doi.org/10.1200/go-25-00206

Vancouver

Feliciano EJG, Jain U, Dee EC, Selokar A, Baclay JR, Wu JF, et al. Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts. JCO Global Oncology. 2025. doi:10.1200/go-25-00206

BibTeX
@article{Feliciano2025,
  author = {Feliciano, Erin Jay G and Jain, Urvish and Dee, Edward Christopher and Selokar, Aryan and Baclay, J Richelyn and Wu, James Fan and Ho, Frances Dominique V and Jain, Bhav and Patel, Tej A and Swami, Nishwant and Yee, Kaisin and Lapen, Kaitlyn and Columbres, Rod Carlo and Bhatt, Navin and Go, Adrian E and Imber, Brandon S and Chitapanarux, Imjai and Ting, Frederic Ivan L and Tremblay, Douglas and Singh, Angelica and Santosa, Damai and Chuncharunee, Suporn and Gan, Gin-Gin and Bhoo-Pathy, Nirmala},
  title = {Hematologic Malignancies Among Adults in Southeast Asia: Incidence, Mortality, and Regional Contexts},
  journal = {JCO Global Oncology},
  year = {2025},
  doi = {10.1200/go-25-00206}
}
Kostenlos starten →